Another report demonstrated that plasma SAM levels were associated with cardiometabolic risk factors such as higher fasting insulin levels, homeostasis model assessment of insulin resistance and TNF-α in a cross-sectional study in humans with metabolic syndrome [34]. The gene discussed is INS; the disease is Insulin resistance.